Clinical Trials Logo

Clinical Trial Summary

Human papillomavirus (HPV)-related oropharyngeal carcinoma are exquisitely radiosensitive. Several studies attempted to reduce the toxicities of treatments through reduced-dose radiation and showed promising results, but all data were collected from non-Chinese areas. Like nasopharyngeal carcinoma, oropharyngeal carcinoma may have different biological behavior and relationship with HPV infection. So the investigators studied whether toxicities reducing treatment with reduced radiation dose and omitted concurrent chemotherapy after good response to induction chemotherapy would maintain survival outcomes while improving tolerability for patients with HPV-positive oropharyngeal carcinoma.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04012502
Study type Interventional
Source Fudan University
Contact Tingting xu, MD
Phone +8618017312903
Email dr_tingtingxu@163.com
Status Recruiting
Phase N/A
Start date July 1, 2019
Completion date December 31, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT04151082 - High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation-Associated Lower Cranial Neuropathy in Oropharyngeal Cancer Survivors Phase 1/Phase 2
Completed NCT04788264 - Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment N/A
Recruiting NCT04874493 - Patient Reported Outcome Post Radiation Therapy or Chemoradiotherapy Patient Care in Patients With Oropharyngeal Cancer
Recruiting NCT05880797 - Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma
Recruiting NCT03215719 - Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma Phase 2
Recruiting NCT03809624 - Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Cancer Phase 2
Recruiting NCT04508829 - Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemotherapy Phase 2
Completed NCT02365844 - Multispectral Imaging to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyngeal Cancer
Recruiting NCT05075980 - HEADLIGHT: Hypofractionated Proton Therapy for Head and Neck Cancers Phase 2
Recruiting NCT04867330 - Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCC N/A
Recruiting NCT05491512 - A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer Phase 2
Completed NCT01440270 - Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer Phase 2
Completed NCT01434394 - Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer Phase 2/Phase 3